TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients
Open Access
- 5 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 15356
Abstract
The survival of patients with glioblastoma (GBM) is poor. The main cause is the presence of glioma stem cells (GSCs), exceptionally resistant to temozolomide (TMZ) treatment. This last may be related to the heterogeneous expression of ion channels, among them TRPML2. Its mRNA expression was evaluated in two different neural stem cell (NS/PC) lines and sixteen GBM stem-like cells by qRT-PCR. The response to TMZ was evaluated in undifferentiated or differentiated GSCs, and in TRPML2-induced or silenced GSCs. The relationship between TRPML2 expression and responsiveness to TMZ treatment was evaluated by MTT assay showing that increased TRPML2 mRNA levels are associated with resistance to TMZ. This research was deepened by qRT-PCR and western blot analysis. PI3K/AKT and JAK/STAT pathways as well as ABC and SLC drug transporters were involved. Finally, the relationship between TRPML2 expression and overall survival (OS) and progression-free survival (PFS) in patient-derived GSCs was evaluated by Kaplan–Meier analysis. The expression of TRPML2 mRNA correlates with worse OS and PFS in GBM patients. Thus, the expression of TRPML2 in GSCs influences the responsiveness to TMZ in vitro and affects OS and PFS in GBM patients.Keywords
Funding Information
- Italian Ministry of Education, University and Research (20178L7WRS, 2017FS5SHL, 2020Z73J5A)
This publication has 69 references indexed in Scilit:
- Concurrent Gene Signatures for Han Chinese Breast CancersPLOS ONE, 2013
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptakeNature Neuroscience, 2013
- Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cellsProceedings of the National Academy of Sciences, 2012
- O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting ConditionsInternational Journal of Molecular Sciences, 2012
- A-to-I RNA editing: The “ADAR” side of human cancerSeminars in Cell & Developmental Biology, 2012
- Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cellsOncology Letters, 2010
- FOXOs, cancer and regulation of apoptosisOncogene, 2008
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Phenotype vs Genotype in the Evolution of Astrocytic Brain TumorsToxicologic Pathology, 2000